FDA issued a Warning Letter to Shilpa Medicare Limited on 10/9/2020 for a later inspection.
483 Shilpa Medicare Sep 2019

483 Shilpa Medicare Sep 2019

Roger Zabinski FDA$119.00 - Available Now

FDA investigators audited the Shilpa Medicare - Polepally, Jadcherla, India facility and issued inspectional observations (via FDA 483) on 06 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Sep 2019
  • Location: Polepally, Jadcherla, India
  • FEI: 3009876430
Add To Cart